manilatimes28m
NKGen Biotech Announces Administration of First Dose of Troculeucel to Stroke Patient Under FDA-Cleared Compassionate Use Program
NKGen explores the use of troculeucel as a potential treatment option for post-stroke patients. SANTA ANA, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) ("NKGen” or the ...
KTTC59m
Trump’s next first speech to Congress is bound to have little resemblance to his last first one
When President Donald Trump speaks to a joint session of Congress on Tuesday, his words are bound to be far different from when he addressed lawmakers at the beginning of his first term.